Radiofrequency Ablation (RFA)/Microwave ablation
Feature Summary
Hepatocellular carcinoma is a malignant tumor in liver. It is now the third leading cause of cancer deaths all over the world. It occurs predominantly in people with liver cirrhosis and chronic hepatitis, such as hepatitis B, hepatitis C, alcoholism and fatty liver disease.
Overview
Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths in the world. Current curative therapies for HCC include resection, transplantation, RFA or MWA.
Features
RFA/MWA is a curative treatment for HCC. Radiofrequency/microwave is generated from the needle, and heat was stimulated to destroy tumors.
Procedure
Before the procedure, sedative medications and analgesic are given. The RFA/MWA needle, guided by either sonography or computed tomography, will be inserted into target tumors. Radiofrequency will be generated to destroy the lesions.
Notification
Potential risks and complications include:
. Bleeding
. Infection
. Biliary tract injury, e.g. biliary stricture, biloma
. Liver failure
. Pneumothorax
. Skin burn
. Tract seeding
. Vascular damage, including portal vein thrombosis, hepatic vein thrombosis, pseudoaneurysm
Estimated Cost
For estimated medical costs, please contact International Medical Services Center.